現職
亞東紀念醫院醫學研究部 研究員 (2022.04-)
核心實驗室
再生醫學及細胞治療實驗室
經歷
骨骼再生與重建研究團隊 研究員
亞東紀念醫院骨科部 研究員
中央研究院基因體研究中心 博士後研究員 (2018-2020)
日本東京大學免疫學所 訪問學者 (2016-2018)
學歷
國立台灣大學免疫學所 博士
榮譽
☆ 2026未來科技獎, 台灣首創CatiPepR:具臨床轉譯與商品化價值的AI胜?,打造具國際競爭力之退化性關節炎精準治療策略
☆ 2026台灣創新技術博覽會發明競賽, CXCL14為基礎之促進軟骨再生的組合物及方法, 銀牌獎
☆ 2025: AI-Enhanced Dual-Function Exosome Therapy BesKne-ExoR: A Precision Regenerative Strategy for Osteoarthritis.
☆ 2025: National Innovation Award 2025, Oral Presentation, AI-Powered Dual-Action BesKne-ExoR Extracellular Vesicle Therapy: Precision Regeneration, Best Potential Award US $2,000, Trophy.
☆ 2024: Manufacture and Medical Technology of Dual-targeted RNA-enriched Extracellular Vesicles, 2024 Future Tech Award
☆ 2023: 15th Pan Pacific Symposium on Stem Cells and Cancer Research, PPSSC, Oral Presentation, US $2,000
☆ 2020: Foundation for the Advanced of Outstanding Scholarship: Traveling Expenses and Accommodation for the International Conference, US $3,000
☆ 2015: Ministry of Science and Technology: Postdoctoral Research Abroad Program (PRAP), US $87,000
專長領域
骨免疫學、組織再生、免疫學、動物疾病模式
專利
<Patent 1>
我方編號 FEH0001PRO
案件名稱(英) NEW APPROACH FOR CARTILAGE REGENERATION
申請人(中) 醫療財團法人徐元智先生醫藥基金會亞東紀念醫院申請人(英) FAR EASTERN MEMORIAL HOSPITAL
發明人(英) Hsiu-Jung Liao, Chih-Hung Chang, Yi-Shan Shen, Chi-Ying Huang
申請日期 2023/09/07 申請案號 63/581,085
<Patent 2>
我方編號 FEH0002PRO
案件名稱(英) METHOD AND PHARMACEUTICAL COMPOSITION FOR TREATING A CARTILAGE DAMAGE USING SOX9 GENE
申請人(中) 醫療財團法人徐元智先生醫藥基金會亞東紀念醫院,國立陽明交通大學
申請人(英) FAR EASTERN MEMORIAL HOSPITAL, National Yang Ming Chiao Tung University
發明人(英) Hsiu-Jung Liao, Chih-Hung Chang, Chi-Ying Huang ,Ly James Lee, Tai-Shan Cheng, Sin-Yu Chen, Andrew Stephen Lee
申請日期 2023/06/08 申請案號 63/506,917
<Patent 3>
我方編號 FEH0007PRO
案件名稱(英) METHOD AND PHARMACEUTICAL COMPOSITION FOR CARTILAGE REGENERATION
申請人(中) 醫療財團法人徐元智先生醫藥基金會亞東紀念醫院
申請人(英) FAR EASTERN MEMORIAL HOSPITAL
發明人(英) Hsiu-Jung Liao, Chih-Hung Chang, Yi-Shan Shen, Chi-Ying Huang
申請日期 2024/04/05 申請案號 63/575,293
個人著作
Hsiu-Jung Liao, Tzu-Chi Liao, Yu-Feng Wu. (2026, Feb) Integrating Regenerative Therapies and Artificial Intelligence for Precision Management of Diabetic Foot Ulcers. Advances in Wound Care (IF: 5.6) Tzu-Yi Huang*, Niann-Tzyy Dai*, Hsiu-Jung Liao*, Ly Hien Doan, Tai-Shan Cheng, Wen-Yu Hsieh, I-Hsuan Lin, Yu-Tang Huang, Chia-Ching Liaw, Hsiao-Sheng Liu, Wei-Ming Cheng, Chun-Li Su, Ching-Wei Yang, Jin-Mei Lai, Mei Nan Tuan, Hui-Kang Liu, Chi-Ying F. Huang. (2026, Jan) Dibifree, a dietary phytomix, improves glycemic control and adiposity via modulation of the gut–pancreas–adipose–immune axis in type 2 diabetes. Food Research International. Volume 223, Part 1, January 2026, 117820 (IF: 8.0) Hsiu-Jung Liao, Kai-Hsiang Shu, Wei-Che Yu, Yen-Ling Chiu. (2025, Dec) Engineering mesenchymal stem cell-derived extracellular vesicles for the treatment of chronic kidney diseases. Tissue Engineering and Regenerative Medicine. Volume 23, pages 1–20, (2026) (IF: 4.1) Hsiu-Jung Liao, Lin-Ping Cheng, Yu-Ching Hsieh, Chien-Sheng Wu, Hung-Chih Yang, I-Tsu Chyuan, Ping-Ning Hsu. (2025, Jul) Interleukin 27 (IL-27) productions in the liver microenvironment confer an immunosuppressive role and enhance hepatitis B viral persistence. Journal of Microbiology, Immunology and Infection. (IF: 3.7) Hsiu-Jung Liao, Hui-Ting Chen, Chih-Hung Chang. (2024, Aug) Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis. Cartilage. (IF: 2.8) Hsiu-Jung Liao, Yi-Ping Yang, Yu-Hao Liu, Huan-Chin Tseng, Teh-Ia Huo, Shih-Hwa Chiou, Chih-Hung Chang. (2024, Aug) Harnessing the potential of mesenchymal stem cells–derived exosomes in degenerative diseases. Regenerative Therapy. (IF: 3.4) Hsiu-Jung Liao, Ping-Ning Hsu. (2024, May) Immunomodulatory effects of extracellular vesicles from mesenchymal stromal cells: Implication for therapeutic approach in autoimmune diseases. The Kaohsiung Journal of Medical Sciences. 1–10. (IF: 3.3) I-Tsu Chyuan, Hsiu-Jung Liao, Tse-Hua Tan, Huai-Chia Chuang, Yu-Chuan Chu, Meng-Hsun Pan, Chien-Sheng Wu, Ching-Liang Chu, Bor-Ching Sheu and Ping-Ning Hsu. (2024, Mar) Association of TRAIL receptor with phosphatase SHP-1 enables repressing T cell receptor signaling and T cell activation through inactivating Lck. Journal of Biomedical Science. (IF: 10.9) Sin-Yu Chen, Yi-Ling Chen, Po-Chen Li, Tai-Shan Cheng, Yeh-Shiu Chu, Yi-Shan Shen, Hsin-Tung Chen, Wei-Ni Tsai, Chien-Ling Huang, Martin Sieber, Yuan-Chieh Yeh, Hsiao-Sheng Liu, Chi-Ling Chiang, Chih-Hung Chang, Andrew S. Lee, Ly James Lee*, Hsiu-Jung Liao*, Hon-Kan Yip* and Chi-Ying F. Huang*. (2024, Mar) Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury. J Biomed Sci . 2024 Mar 19;31(1):30. doi: 10.1186/s12929-024-01019-4. (IF: 10.9)(連結) Hung-Wei Chen, Chi-Hsiang Huang, Chi-Ying F. Huang, Chih-Hung Chang, Hsiu-Jung Liao*. (2023, Oct) Distinct subsets of synovial fibroblasts control cartilage destruction in joint diseases. Clin Exp Rheumatol . 2023 Sep 6. doi: 10.55563/clinexprheumatol/txl9rm. (IF: 3.7) (連結) Yu-Chun Chen*, Hsiu-Jung Liao*, Yuan-Ming Hsu, Yi-Shan Shen, Chih-Hung Chang. (2022, Apr) Delivery of Mesenchymal Stem Cell in Dialdehyde Methylcellulose-Succinyl-Chitosan Hydrogel Promotes Chondrogenesis in a Porcine Model. Polymers (Basel), 5;14(7):1474. (IF: 5.0) (連結) Chia-Yin Lee, Anh Thuc Nguyen, Ly Hien Doan, Li-Wei Chu, Chih-Hung Chang, Hui-Kang Liu, I-Lin Lee, Teng-Hsu Wang, Jin-Mei Lai, Shih-Ming Tsao, Hsiu-Jung Liao*, Yueh-Hsin Ping*, Chi-Ying F. Huang*. (2023 Feb) Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects. Viruses 2023, 15(3), 641; https://doi.org/10.3390/v15030641 (IF: 5.818) (連結) Yu-Chen Tsai, Tai-Shan Cheng, Hsiu-Jung Liao, Ming-Hsi Chuang, Hui-Ting Chen, Chun-Hung Chen, Kai-Ling Zhang, Chih-Hung Chang, Po-Cheng Lin, Chi-Ying F. Huang (2022, Nov) Mesenchymal Stem Cell Secreted-Extracellular Vesicles are Involved in Chondrocyte Production and Reduce Adipogenesis during Stem Cell Differentiation. Tissue Engineering and Regenerative Medicine 19:1295–1310. (IF: 4.169)(連結) Ting-Hui Chang, Chien-Sheng Wu, Shih-Hwa Chiou, Chih-Hung Chang*, Hsiu-Jung Liao*, (2022, Jul) Adipose-Derived Stem Cell Exosomes as a Novel Anti-Inflammatory Agent and the Current Therapeutic Targets for Rheumatoid Arthritis. Biomedicines 2022 Jul 18;10(7):1725.doi: 10.3390/biomedicines10071725. (IF: 4.757)(連結) Yu-Hung Chen, Hsiu-Jung Liao, Shang Ming Lin, Chih-Hung Chang, Syang-Peng Rwei, Tsung-Yu Lan (2022, June) Radiographic outcomes of the treatment of complex femoral shaft fractures (AO/OTA 32-C) with intramedullary nailing: a retrospective analysis of different techniques. Journal of International Medical Research, 50(6) 1–13. (IF: 1.36) I-Tsu Chyuan, Ching-Liang Chu, Chia-Lang Hsu, Meng-Hsun Pan, Hsiu-Jung Liao, Chien-Sheng Wu, Ping-Ning Hsu. (2022 Mar) T Cell-Specific Deletion of TRAIL Receptor Reveals Its Critical Role for Regulating Pathologic T Cell Activation and Disease Induction in Experimental Autoimmune Encephalomyelitis. J Immunol. 2022 Apr 1;208(7):1534-1544. doi: 10.4049/jimmunol.2100788. (IF: 5.446)(連結) Hsiu-Jung Liao, Ching-Liang Chu, Szu-Chieh Wang, Hua-Yi Lee, Chien-Sheng Wu. (2022) Increased HIF-1α expression in T cells and associated with enhanced Th17 pathway in systemic lupus erythematosus. Journal of the Formosan Medical Association 2022 May 19;S0929-6646(22)00188-7.doi: 10.1016/j.jfma.2022.05.003. (IF: 3.871)(連結) Hsiu-Jung Liao, Chih-Hung Chang, Chi-Ying F. Huang, Hui-Tung Chen. (2022, Mar) Potential of Using Infrapatellar-Fat-Pad-Derived Mesenchymal Stem Cells for Therapy in Degenerative Arthritis: Chondrogenesis, Exosomes, and Transcription Regulation. Biomolecules 2022 Mar; 12(3): 386. (IF: 6.064)(連結) Chiao-Feng Cheng, Hsiu-Jung Liao, Chien-Sheng Wu. (2022, Feb) Tissue microenvironment dictates inflammation and disease activity in rheumatoid arthritis. Journal of the Formosan Medical Association. (IF: 3.871)(連結) Hsiu-Jung Liao, Hwei-Fang Tsai, Chien-Sheng Wu, I-Tsu Chyuan, Ping-Ning Hsu (2019, Jan). TRAIL inhibits RANK signaling and suppresses osteoclast activation via inhibiting lipid raft assembly and TRAF6 recruitment. Cell Death and Disease, 10(2):77. (IF: 9.705) (連結) I-Tsu Chyuan, Hwei-Fang Tsai, Hsiu-Jung Liao, Chien-Sheng Wu, Ping-Ning Hsu (2018, Sep). An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. Cellular Molecular Immunology, 15(9):846-857. (IF: 22.096)(連結) Hwei-Fang Tsai, Chien-Sheng Wu, Yi-Lin Chen, Hsiu-Jung Liao, I-Tsu Chyuan, Ping-Ning Hsu (2016, May). Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis. Journal of Molecular Medicine (Berl), 94(5):545-56. (IF: 5.606) (連結) Hsiu-Jung Liao, I-Tsu Chyuan, Chien-Sheng Wu, Shu-Wha Lin, Kun-Hug Chen, Hwei-Fang Tsai, Ping-Ning Hsu. (2015, Jan). Increased neutrophil infiltration, IL-1 production and a SAPHO syndrome-like phenotype in PSTPIP2-deficient mice. Rheumatology (Oxford), 54(7), 1317-1326. MOST 98-2320-B-002-049-MY3. (IF: 7.046)(連結) Horng-Tay Tzeng, Hwei-Fang Tsai, I-Tsu Chyuan, Hsiu-Jung Liao, Chun-Jen Chen, Pei-Jer Chen, Ping-Ning Hsu (2014, Jul). Tumor necrosis factor-alpha induced by hepatitis B virus core mediating the immune response for hepatitis B viral clearance in mice model. PLoS One, 21;9(7): e103008. (IF: 3.752)(連結) Wei-Chang Lin, Hwei-Fang Tsai, Hsiu-Jung Liao, Chen-Hsi Tang, Yi-Ying Wu, Ping-I Hsu, Ann-Lii Cheng, Ping-Ning Hsu (2014, Mar). Helicobacter pylori sensitizes TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP. Cell Death and Disease, 6;5: e1109. MOST 102-2320-B-038-040-MY3. (IF:9.705)(連結) Shu-Chun Chuang, Hsiu-Jung Liao, Ching-Ju Lia, Gwo-Jaw Wang, Je-Ken Chang, Mei-Ling Ho (2013, Aug). Simvastatin enhances human osteoblast proliferation involved in mitochondrial energy generation. European Journal of Pharmacology, 714(1-3):74-82. NSC 94-2314-B-037-023. (IF: 5.195)(連結) Horng-Tay Tzeng, Hwei-Fang Tsai, Hsiu-Jung Liao, Yi-Jiun Lin, Lie-ping Chen, Pei-Jer Chen, Ping-Ning Hsu (2012, Jun). PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model. PLoS One, 7(6): e39179. (IF: 3.752) (連結) Men-Luh Yen, Ping-Ning Hsu, Hsiu-Jung Liao, Be-Han Lee, Hwei-Fang Tsai (2012, Jun). TRAF-6 dependent signaling pathway is essential for TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation. PLoS One, 7(6): e38048. (IF: 3.752) (連結) Shih-Chia Huang, Hwei-Fang Tsai, Horng-Tay Tzeng, Hsiu-Jung Liao, Ping-Ning Hsu (2011, Jan). Lipid raft assembly and Lck recruitment in TRAIL costimulation mediates NF-κB activation and T cell proliferation. Journal of Immunology, 186(2):931-9. 經濟部: NHRI-EX95-9532SI. (IF:5.446) (連結) Je-Ken Chang, Ching-Ju Li, Hsiu-Jung Liao, Chih-Kuang Wang, Gwo-Jaw Wang, Mei-Ling Ho (2009, Apr). Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts. Toxicology, 258(2-3):148-56. 經濟部: NHRI-EX97-9615EP. (IF: 4.571) (連結) Mei-Ling Ho, Yi-Huei Chen, Hsiu-Jung Liao, Chung-Hwan Chen, Shao-Hung Hung, Mon-Juan Lee, Yin-Chih Fu, Yan-Hsiung Wang, Gwo-Jaw Wang, Je-Ken Chang (2009, Apr). Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats. European Journal of Clinical Investigation, 39(4):296-303. NSC 93-2314-B-037-053. (IF: 5.722)(連結) 廖秀蓉,張至宏,黃奇英(2023年09月)。再生醫療雙法草案遭遇卡關?台灣再生醫療發展面臨的爭議與挑戰。科學月刊,501期。(本人為第一作者) 廖秀蓉(2022年05月)。脂肪幹細胞分泌外泌體之免疫調控-以類風濕性關節炎之無細胞治療為例。景福醫訊,39(5), 11-13. (本人為第一作者) 張至宏,廖秀蓉(2021年09月)。從退化性關節炎看<特管法>的個案審查。科學月刊,621(9), 16-21. (本人為第一作者) 張至宏,廖秀蓉,雷涵?,陳郁君(2021年04月)。退化性關節炎與軟骨缺損的再生醫學治療。高雄醫師會誌,29(1),72-81.Invited Speaker
Nov. 8, 2023. Encapsulation of Therapeutic mRNA in Extracellular Vesicles for the Treatment of Osteoarthritis, Asian Federation for Pharmaceutical Sciences (AFPS), Hanoi, Viet Nam. Apr. 22, 2024. Intraarticularly delivery mRNA-encapsulating extracellular vesicles for osteoarthritis therapy, China Medical University, Taiwan. Jun. 29, 2024. Intra-articular Delivery of mRNA-Encapsulated Extracellular Vesicles for Osteoarthritis Treatment, TORS & CAOS International Conference, Taiwan. Oct. 22, 2024. Extracellular vesicles in knee osteoarthritis, National Biotechnology Research Park, Taiwan. Nov. 17, 2024. Extracellular vesicles in knee osteoarthritis, The Pharmacogenomics Society of Taiwan, Taiwan. Nov. 23, 2024. New Approach for Cartilage Regeneration, 2024 台灣細胞醫療協會年會, Taipei, Taiwan. Jan. 21, 2025, AI-driven Extracellular Vesicles for Knee Osteoarthritis, Kaohsiung Medical University, Kaohsiung. Feb. 21, 2025, Extracellular Vesicle for Autoimmune Diseases, National Yang Ming Chiao Tung University, Taipei, Taiwan. Feb. 22, 2025, Extracellular Vesicles as a Treatment for Knee Osteoarthritis, The Development Prospects of Exosomes and Stem Cells: From Basic Research to Therapeutic Strategies, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Mar. 12, 2025, AI-Driven Extracellular Vesicles for Osteoarthritis, Malvern Panalytical Conference, National Taiwan University, Taipei, Taiwan. Mar. 29, 2025, Extracellular Vesicles as a Therapeutic Approach for Cartilage Disorders, Formosa Association Regenerative Medicine, Taipei, Taiwan. Apr. 15, 2025, Sharing on writing techniques and strategies for National Science and Technology Council (NSTC) grant proposals, Far Eastern Memorial Hospital, New Taipei City, Taiwan. May 21, 2025, Sharing on writing techniques and strategies for National Science and Technology Council (NSTC) grant proposals, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Jun. 5, 2025, Precision Regeneration: AI-Driven Extracellular Vesicles for Cartilage Disorders., Taipei, Taiwan. Jun. 5, 2025, AI-driven Extracellular Vesicles as a Therapeutic Approach for Cartilage Disorders, Taipei, Taiwan. Jun. 20, 2025, Precision Regeneration: AI-Driven Extracellular Vesicles for Cartilage Disorders., Vietnam. Sep. 27, 2025, Precision Regeneration: AI-Driven Extracellular Vesicles for Cartilage Disorders., Chang Gung Memorial Hospital, Taoyuan City. Oct. 10, 2025, Precision Regeneration: AI-Driven Extracellular Vesicles for Cartilage Disorders., 2025 KMU International Conference on BioMedicine (KMU-ICOBM 2025), Kaohsiung Medical University, Kaohsiung. Oct. 14, 2025, Precision Regeneration: AI-Driven Extracellular Vesicles for Cartilage Disorders., Japanese Society of Extracellular Vesicle, Osaka, Japan. Dec. 5, 2025, AI-Driven Dual-Action Extracellular Vesicle Therapy for Osteoarthritis: Toward Precision Cartilage Regeneration, Healthcare+ Expo Taiwan, Taipei, Taiwan. Jan. 23, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion: A Next-Generation Precision Regenerative Therapy for Osteoarthritis, Extracellular Vesicles Conference 2026, Shenzhen City, China. Jan. 30, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion: A Next-Generation Precision Regenerative Therapy for Osteoarthritis, 2026 International Summit on Extracellular Vesicles, Stem Cells, Regulatory Science, and Innovative Therapies, National Yang Ming Chao Tung University, Taipei City, Taiwan. Jan. 31, 2026, A New Therapeutic Paradigm for Biologic-Refractory Rheumatoid Arthritis: miRNA Delivery Coupled with Target Modulation, Extracellular Vesicles Conference 2026, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Mar. 6, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion: A Next-Generation Precision Regenerative Therapy for Osteoarthritis, Department of Medical Research, Taichung Veterans General Hospital, Taichung City, Taiwan.25. Mar. 10, 2026, Building Al-Driven Living Drug Factories: Biointelligent Peptide Reprogramming of MSCs for Next-Generation Extracellular Vesicle Therapeutics, National Yang Ming Chao Tung University, Taipei City, Taiwan. Mar. 29, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion, Taipei Far Eastern Telecom Park, New Taipei City, Taiwan. Jun. 22, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion: A Next-Generation Precision Regenerative Therapy for Osteoarthritis, National Institute of Medicinal Materials, Hanoi, Vietnam. Jun. 23, 2026, Plant-Derived Extracellular Vesicles Reprogram the Diabetic Wound Microenvironment to Restore Regeneration, Applications of Exosomes in Rejuvenation and Aesthetic Medicine, Hanoi, Vietnam. Jun. 26, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion: A Next-Generation Precision Regenerative Therapy for Osteoarthritis, National Yang Ming Chao Tung University, Taipei City, Taiwan. Jul. 14, 2026, AI-Engineered Biointelligent Peptide Reprograms Mesenchymal Stem Cells for Extracellular Vesicle Secretion: A Next-Generation Precision Regenerative Therapy for Osteoarthritis, Chulalongkorn University, Bangkok, Thailand. Sep. 15, 2026, AI-Engineered Extracellular Vesicles: A New Frontier for Disease-Modifying Osteoarthritis Therapy Extracellular Vesicles, National Yang Ming Chao Tung University, Taipei City, Taiwan. Nov. 14, 2026, AI-Engineered Extracellular Vesicles: A New Frontier for Disease-Modifying Osteoarthritis Therapy Extracellular Vesicles, Multiomics and Precision Medicine Joint Conference 2026. National Cheng Kung University, Tainan city, Taiwan. Dec. 3, 2026, AI-Engineered Extracellular Vesicles: A New Frontier for Disease-Modifying Osteoarthritis Therapy Extracellular Vesicles, Conference 2026 (SELECTBIO), Kuala Lumpur, Malaysia.
醫學研究部研究員 廖秀蓉 博士
(Hsiu-Jung Liao, PhD.)
E-mail:liaohsiujung@gmail.com (分機4566)



